Medication Combining Heart Attack and Stroke Prevention Gains WHO Approval
St. Louis, MO – Polypills, a combination of medications designed to target cardiovascular conditions, have long been recommended to reduce the risk of heart attacks, strokes, and other related causes of death. Despite being introduced almost 25 years ago and backed by significant research, the use of polypills globally remains minimal. However, a recent study conducted by researchers at the Washington University School of Medicine in St. Louis sheds new light on the benefits of …